Table 1 |
|||||
|
Characteristics and SF FSTL1 levels in the subjects investigateda |
|||||
|
Con |
OA |
RA |
Male OA |
Female OA |
|
|
|
|||||
|
Number |
6 |
42 |
16 |
11 |
31 |
|
Age (years)b |
32 (30-49) |
67 (60-72) |
61 (54-70) |
70 (55-75) |
67 (60-72) |
|
Sex (M/F) |
4/2 |
11/31 |
2/14 |
- |
- |
|
Disease duration (years)b |
- |
1.0 (0.5-3.0) |
2.0 (0.5-4.5) |
0.9 (0.2-2.8) |
1.0 (0.5-6.0) |
|
FSTL1 levels (μg/L)b |
6.80 |
15.66 |
39.80 |
11.65 |
16.54 |
|
(6.02-7.32) |
(12.04-19.80) |
(22.74-273.80) |
(8.57-13.50) |
(14.09-27.53) |
|
|
|
|||||
|
aIncluded all subjects for whom SF samples were available and part of subjects for whom tissue samples were available. bExpressed as the median (25th to 75th percentile). Con, control trauma patients; FSTL1, follistatin-like protein 1; OA, osteoarthritis; RA, rheumatoid arthritis. |
|||||
|
Wang et al. Arthritis Research & Therapy 2011 13:R193 doi:10.1186/ar3522 |
|||||
